Clinical trial
A 12 Week, Phase II Trial of the Safety, Pharmacokinetics, and Efficacy of INV-144 Compared With Losartan Potassium in Patients With Hypertension and Type 2 Diabetes Mellitus With Nephropathy
NCT01398423 is registered in ClinicalTrials.gov with InVasc Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A 12 Week, Phase II Trial of the Safety, Pharmacokinetics, and Efficacy of INV-144 Compared With Losartan Potassium in Patients With Hypertension and Type 2 Diabetes Mellitus With Nephropathy
- Lead sponsor
- InVasc Therapeutics, Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2011
- Completion date
- July 31, 2012
- Enrollment
- 88 (actual)
- Sites
- 19
Conditions
As the registry lists them; a condition with its own page is linked.